메뉴 건너뛰기




Volumn 11, Issue 5, 2006, Pages 496-501

A novel approach to immunosuppression: Targeting the alloimmune mechanisms of graft rejection

Author keywords

Immunosuppression; Lung transplantation; Mechanisms; Rejection

Indexed keywords

ALEMTUZUMAB; ANTIMETABOLITE; AZATHIOPRINE; AZITHROMYCIN; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LEUKOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 33748775743     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000244651.82791.90     Document Type: Review
Times cited : (1)

References (51)
  • 1
    • 33646356240 scopus 로고    scopus 로고
    • Clinical trials of immunosuppression in lung transplantation: A coming of age
    • Fisher AJ. Clinical trials of immunosuppression in lung transplantation: a coming of age. Transplantation 2006; 81:980-981.
    • (2006) Transplantation , vol.81 , pp. 980-981
    • Fisher, A.J.1
  • 2
    • 25844472471 scopus 로고    scopus 로고
    • Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation
    • Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24:1454-1459.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1454-1459
    • Christie, J.D.1    Carby, M.2    Bag, R.3
  • 3
    • 3042745417 scopus 로고    scopus 로고
    • Management of an ABO-incompatible lung transplant
    • Banner NR, Rose ML, Cummins D, et al. Management of an ABO-incompatible lung transplant. Am J Transplant 2004; 4:1192-1196.
    • (2004) Am J Transplant , vol.4 , pp. 1192-1196
    • Banner, N.R.1    Rose, M.L.2    Cummins, D.3
  • 4
    • 0021844156 scopus 로고
    • Lung allograft rejection in the rat. III. Corresponding morphological rejection phases in various rat strain combinations
    • Prop J, Wildevuur CR, Nieuwenhuis P. Lung allograft rejection in the rat. III. Corresponding morphological rejection phases in various rat strain combinations. Transplantation 1985; 40:132-136.
    • (1985) Transplantation , vol.40 , pp. 132-136
    • Prop, J.1    Wildevuur, C.R.2    Nieuwenhuis, P.3
  • 5
    • 0028676654 scopus 로고
    • Pretreatment of kidney allografts with monoclonal antibodies to CD45: Results of a multicentre study CD45 Study Group
    • Goldberg LC. Pretreatment of kidney allografts with monoclonal antibodies to CD45: results of a multicentre study CD45 Study Group. Transplant Int 1994; 7 (Suppl. 1):S252-S254.
    • (1994) Transplant Int , vol.7 , Issue.1 SUPPL.
    • Goldberg, L.C.1
  • 6
    • 2942578878 scopus 로고    scopus 로고
    • HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection
    • Girnita AL, McCurry KR, Iacono AT, et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 2004; 23:1135-1141.
    • (2004) J Heart Lung Transplant , vol.23 , pp. 1135-1141
    • Girnita, A.L.1    McCurry, K.R.2    Iacono, A.T.3
  • 7
    • 0030995631 scopus 로고    scopus 로고
    • Influence of panel-reactive antibody on survival and rejection after lung transplantation
    • Gammie JS, Pham SM, Colson YL, et al. Influence of panel-reactive antibody on survival and rejection after lung transplantation. J Heart Lung Transplant 1997; 16:408-415.
    • (1997) J Heart Lung Transplant , vol.16 , pp. 408-415
    • Gammie, J.S.1    Pham, S.M.2    Colson, Y.L.3
  • 8
    • 0033945872 scopus 로고    scopus 로고
    • Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients
    • Lau CL, Palmer SM, Posther KE, et al. Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg 2000; 69:1520-1524.
    • (2000) Ann Thorac Surg , vol.69 , pp. 1520-1524
    • Lau, C.L.1    Palmer, S.M.2    Posther, K.E.3
  • 9
    • 25844508502 scopus 로고    scopus 로고
    • C4d staining of pulmonary allograft biopsies: An immunoperoxidase study
    • Wallace WD, Reed EF, Ross D, et al. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant 2005; 24:1565-1570.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1565-1570
    • Wallace, W.D.1    Reed, E.F.2    Ross, D.3
  • 10
    • 0036871663 scopus 로고    scopus 로고
    • What's in the pipeline? New immunosuppressive drugs in transplantation
    • Vincenti F. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant 2002; 2:898-903.
    • (2002) Am J Transplant , vol.2 , pp. 898-903
    • Vincenti, F.1
  • 11
    • 14644391619 scopus 로고    scopus 로고
    • The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
    • Fisher AJ, Rutherford RM, Bozzino J, et al. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2005; 5:537-543.
    • (2005) Am J Transplant , vol.5 , pp. 537-543
    • Fisher, A.J.1    Rutherford, R.M.2    Bozzino, J.3
  • 12
    • 24344485629 scopus 로고    scopus 로고
    • Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients
    • Shitrit D, Bendayan D, Gidon S, et al. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 2005; 24:1440-1443. This series suggests a slowing in the rate of progression of BOS by the administration of long-term azithromycin having excluded some potential confounding factors. It suggests that a prospective randomized trial is needed.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1440-1443
    • Shitrit, D.1    Bendayan, D.2    Gidon, S.3
  • 13
    • 0038216660 scopus 로고    scopus 로고
    • Statin use is associated with improved function and survival of lung allografts
    • Johnson BA, Iacono AT, Zeevi A, et al. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003; 167:1271-1278.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 1271-1278
    • Johnson, B.A.1    Iacono, A.T.2    Zeevi, A.3
  • 14
    • 0036159109 scopus 로고    scopus 로고
    • Risk factors for bronchiolitis obliterans: A systematic review of recent publications
    • Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002; 21:271-281.
    • (2002) J Heart Lung Transplant , vol.21 , pp. 271-281
    • Sharples, L.D.1    McNeil, K.2    Stewart, S.3    Wallwork, J.4
  • 15
    • 0036123192 scopus 로고    scopus 로고
    • Success of lung transplantation without surveillance bronchoscopy
    • Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002; 21:319-326.
    • (2002) J Heart Lung Transplant , vol.21 , pp. 319-326
    • Valentine, V.G.1    Taylor, D.E.2    Dhillon, G.S.3
  • 16
    • 0037348592 scopus 로고    scopus 로고
    • Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation
    • Davis RD Jr, Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125:533-542.
    • (2003) J Thorac Cardiovasc Surg , vol.125 , pp. 533-542
    • Davis Jr., R.D.1    Lau, C.L.2    Eubanks, S.3
  • 17
    • 23744489108 scopus 로고    scopus 로고
    • Registry of the International Society for Heart and Lung Transplantation: 22nd Official adult lung and heart-lung transplant report - 2005
    • Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: 22nd Official adult lung and heart-lung transplant report - 2005. J Heart Lung Transplant 2005; 24:956-967.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 956-967
    • Trulock, E.P.1    Edwards, L.B.2    Taylor, D.O.3
  • 18
    • 0035957199 scopus 로고    scopus 로고
    • Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody
    • Garrity ER Jr, Villanueva J, Bhorade SM, et al. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001; 71:773-777.
    • (2001) Transplantation , vol.71 , pp. 773-777
    • Garrity Jr., E.R.1    Villanueva, J.2    Bhorade, S.M.3
  • 19
    • 0035660725 scopus 로고    scopus 로고
    • Induction therapy in lung transplantation: A prospective, controlled clinical trial comparing OKT3, antithymocyte globulin, and daclizumab
    • Brock MV, Borja MC, Ferber L, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, antithymocyte globulin, and daclizumab. J Heart Lung Transplant 2001; 20:1282-1290.
    • (2001) J Heart Lung Transplant , vol.20 , pp. 1282-1290
    • Brock, M.V.1    Borja, M.C.2    Ferber, L.3
  • 20
    • 24344440228 scopus 로고    scopus 로고
    • A comparison of basiliximab and antithymocyte globulin as induction agents after lung transplantation
    • Hachem RR, Chakinala MM, Yusen RD, et al. A comparison of basiliximab and antithymocyte globulin as induction agents after lung transplantation. J Heart Lung Transplant 2005; 24:1320-1326.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1320-1326
    • Hachem, R.R.1    Chakinala, M.M.2    Yusen, R.D.3
  • 21
    • 29544447695 scopus 로고    scopus 로고
    • Comparative study of basiliximab treatment in lung transplantation
    • Borro JM, De la Torre M, Miguelez C, et al. Comparative study of basiliximab treatment in lung transplantation. Transplant Proc 2005; 37:3996-3998.
    • (2005) Transplant Proc , vol.37 , pp. 3996-3998
    • Borro, J.M.1    De La Torre, M.2    Miguelez, C.3
  • 24
    • 33748801018 scopus 로고    scopus 로고
    • Campath-1H induction and maintenance drug minimization in lung transplantation: One-year outcomes and comparison with triple drug immunosuppression with or without dacluzimab induction
    • Madrid, Spain, 5-8 April Abstract 238
    • McCurry KR, Zaldonis DB, Husain S, et al. Campath-1H induction and maintenance drug minimization in lung transplantation: One-year outcomes and comparison with triple drug immunosuppression with or without dacluzimab induction. 26th Annual Meeting of the International Society for Heart and Lung Transplantation. Madrid, Spain, 5-8 April 2006, Abstract 238.
    • (2006) 26th Annual Meeting of the International Society for Heart and Lung Transplantation
    • McCurry, K.R.1    Zaldonis, D.B.2    Husain, S.3
  • 25
    • 13444251376 scopus 로고    scopus 로고
    • Overview of tacrolimus-based immunosuppression after heart or lung transplantation
    • Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant 2005; 24:119-130.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 119-130
    • Reichenspurner, H.1
  • 26
    • 0029115077 scopus 로고
    • Clinical trial of tacrolimus versus cyclosporine in lung transplantation
    • Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60:580-584; discussion 4-5.
    • (1995) Ann Thorac Surg , vol.60 , pp. 580-584
    • Keenan, R.J.1    Konishi, H.2    Kawai, A.3
  • 27
    • 0035047505 scopus 로고    scopus 로고
    • Tacrolimus versus cyclosporine after lung transplantation: A prospective, open, randomized twocenter trial comparing two different immunosuppressive protocols
    • Treede H, Klepetko W, Reichenspurner H, et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized twocenter trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001; 20:511-517.
    • (2001) J Heart Lung Transplant , vol.20 , pp. 511-517
    • Treede, H.1    Klepetko, W.2    Reichenspurner, H.3
  • 28
    • 29144475502 scopus 로고    scopus 로고
    • Association between cyclosporine concentrations at 2 h postdose and clinical outcomes in de novo lung transplant recipients
    • Akhlaghi F, Gonzalez L, Trull AK. Association between cyclosporine concentrations at 2 h postdose and clinical outcomes in de novo lung transplant recipients. J Heart Lung Transplant 2005; 24:2120-2128. C2 monitoring of cyclosporin levels was shown to be the best predictor of exposure to this drug and facilitated reduced rates of acute rejection. No benefit in terms of renal toxicity was demonstrated.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 2120-2128
    • Akhlaghi, F.1    Gonzalez, L.2    Trull, A.K.3
  • 29
    • 23744452873 scopus 로고    scopus 로고
    • Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (neoral)
    • Jaksch P, Kocher A, Neuhauser P, et al. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (neoral). J Heart Lung Transplant 2005; 24:1076-1080.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1076-1080
    • Jaksch, P.1    Kocher, A.2    Neuhauser, P.3
  • 30
    • 5144228631 scopus 로고    scopus 로고
    • Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation
    • Glanville AR, Morton JM, Aboyoun CL, et al. Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation. J Heart Lung Transplant 2004; 23:1170-1174.
    • (2004) J Heart Lung Transplant , vol.23 , pp. 1170-1174
    • Glanville, A.R.1    Morton, J.M.2    Aboyoun, C.L.3
  • 31
    • 5144234046 scopus 로고    scopus 로고
    • Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation
    • Morton JM, Aboyoun CL, Malouf MA, et al. Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation. J Heart Lung Transplant 2004; 23:1035-1039.
    • (2004) J Heart Lung Transplant , vol.23 , pp. 1035-1039
    • Morton, J.M.1    Aboyoun, C.L.2    Malouf, M.A.3
  • 32
    • 0037489574 scopus 로고    scopus 로고
    • Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors
    • Ray JE, Keogh AM, McLachlan AJ, Akhlaghi F. Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors. J Heart Lung Transplant 2003; 22:715-722.
    • (2003) J Heart Lung Transplant , vol.22 , pp. 715-722
    • Ray, J.E.1    Keogh, A.M.2    McLachlan, A.J.3    Akhlaghi, F.4
  • 33
    • 0042387737 scopus 로고    scopus 로고
    • Sublingual tacrolimus for immunosuppression in lung transplantation: A potentially important therapeutic option in cystic fibrosis
    • Reams BD, Palmer SM. Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. Am J Respir Med 2002; 1:91-98.
    • (2002) Am J Respir Med , vol.1 , pp. 91-98
    • Reams, B.D.1    Palmer, S.M.2
  • 34
    • 0042059633 scopus 로고    scopus 로고
    • Utility of sublingual tacrolimus in cystic fibrosis patients after lung transplantation
    • Reams D, Rea J, Davis D, Palmer S. Utility of sublingual tacrolimus in cystic fibrosis patients after lung transplantation. J Heart Lung Transplant 2001; 20:207-208.
    • (2001) J Heart Lung Transplant , vol.20 , pp. 207-208
    • Reams, D.1    Rea, J.2    Davis, D.3    Palmer, S.4
  • 35
    • 33646367430 scopus 로고    scopus 로고
    • Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients
    • McNeil K, Glanville AR, Wahlers T, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006; 81:998-1003. This prospective study was one of the first and largest trials of immunosuppression after lung transplantation. It did not show a significant benefit between the treatment groups but highlights the methodological difficulties in treating this fragile patient group.
    • (2006) Transplantation , vol.81 , pp. 998-1003
    • McNeil, K.1    Glanville, A.R.2    Wahlers, T.3
  • 36
    • 3242756741 scopus 로고    scopus 로고
    • Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
    • Offman J, Opelz G, Doehler B, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004; 104:822-828.
    • (2004) Blood , vol.104 , pp. 822-828
    • Offman, J.1    Opelz, G.2    Doehler, B.3
  • 37
    • 19244366021 scopus 로고    scopus 로고
    • Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
    • Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349:847-858.
    • (2003) N Engl J Med , vol.349 , pp. 847-858
    • Eisen, H.J.1    Tuzcu, E.M.2    Dorent, R.3
  • 38
    • 33644856861 scopus 로고    scopus 로고
    • Everolimus versus azathioprine in maintenance lung transplant recipients: An international, randomized, double-blind clinical trial
    • Snell GI, Valentine VG, Vitulo P, et al. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. Am J Transplant 2006; 6:169-177. This study showed very promising early results in terms of a reduction in acute rejection and possibly a reduction in the rate of decline in the forced expiratory volume in 1 s. The benefit was less at 24 months, but highlights problems with withdrawal as a result of toxicity of the study drug.
    • (2006) Am J Transplant , vol.6 , pp. 169-177
    • Snell, G.I.1    Valentine, V.G.2    Vitulo, P.3
  • 40
    • 0036253476 scopus 로고    scopus 로고
    • Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
    • Snell GI, Levvey BJ, Chin W, et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002; 21:540-546.
    • (2002) J Heart Lung Transplant , vol.21 , pp. 540-546
    • Snell, G.I.1    Levvey, B.J.2    Chin, W.3
  • 41
    • 0027156414 scopus 로고
    • Management of lung transplant rejection
    • Trulock EP. Management of lung transplant rejection. Chest 1993; 103:1566-1576.
    • (1993) Chest , vol.103 , pp. 1566-1576
    • Trulock, E.P.1
  • 42
    • 0028237343 scopus 로고
    • Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation
    • Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant 1994; 13:514-519.
    • (1994) J Heart Lung Transplant , vol.13 , pp. 514-519
    • Shennib, H.1    Massard, G.2    Reynaud, M.3    Noirclerc, M.4
  • 43
    • 0025896104 scopus 로고
    • Successful treatment of steroidresistant double-lung allograft rejection with orthoclone OKT3
    • Shennib H, Mercado M, Nguyen D, et al. Successful treatment of steroidresistant double-lung allograft rejection with orthoclone OKT3. Am Rev Respir Dis 1991; 144:224-226.
    • (1991) Am Rev Respir Dis , vol.144 , pp. 224-226
    • Shennib, H.1    Mercado, M.2    Nguyen, D.3
  • 44
    • 0030755483 scopus 로고    scopus 로고
    • Tacrolimus: A superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation
    • Meiser BM, Uberfuhr P, Fuchs A, et al. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. J Heart Lung Transplant 1997; 16:795-800.
    • (1997) J Heart Lung Transplant , vol.16 , pp. 795-800
    • Meiser, B.M.1    Uberfuhr, P.2    Fuchs, A.3
  • 45
    • 0344541764 scopus 로고    scopus 로고
    • Tacrolimus as a rescue immunosuppressant after heart and lung transplantation
    • The US Multicenter FK506 Study Group
    • Mentzer RM Jr, Jahania MS, Lasley RD. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The US Multicenter FK506 Study Group. Transplantation 1998; 65:109-113.
    • (1998) Transplantation , vol.65 , pp. 109-113
    • Mentzer Jr., R.M.1    Jahania, M.S.2    Lasley, R.D.3
  • 46
    • 0031658689 scopus 로고    scopus 로고
    • Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: Preliminary experience
    • Ross DJ, Waters PF, Levine M, et al. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience. J Heart Lung Transplant 1998; 17:768-774.
    • (1998) J Heart Lung Transplant , vol.17 , pp. 768-774
    • Ross, D.J.1    Waters, P.F.2    Levine, M.3
  • 47
    • 0030724184 scopus 로고    scopus 로고
    • Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation
    • Whyte RI, Rossi SJ, Mulligan MS, et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1997; 64:945-948.
    • (1997) Ann Thorac Surg , vol.64 , pp. 945-948
    • Whyte, R.I.1    Rossi, S.J.2    Mulligan, M.S.3
  • 48
    • 11144354110 scopus 로고    scopus 로고
    • International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection
    • Sarahrudi K, Estenne M, Corris P, et al. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. J Thorac Cardiovasc Surg 2004; 127:1126-1132.
    • (2004) J Thorac Cardiovasc Surg , vol.127 , pp. 1126-1132
    • Sarahrudi, K.1    Estenne, M.2    Corris, P.3
  • 49
    • 32844468996 scopus 로고    scopus 로고
    • Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation
    • Groetzner J, Wittwer T, Kaczmarek I, et al. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation. Transplantation 2006; 81:355-360. This prospective study showed stabilization of graft function after a diagnosis of chronic rejection, and suggests the need for early intervention.
    • (2006) Transplantation , vol.81 , pp. 355-360
    • Groetzner, J.1    Wittwer, T.2    Kaczmarek, I.3
  • 50
    • 30444434900 scopus 로고    scopus 로고
    • A randomized trial of inhaled cyclosporine in lung-transplant recipients
    • Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006; 354:141-150. This prospective study suggests that this novel route of drug administration is safe and tolerable, and although it did not reduce rates of acute rejection suggested improved survival.
    • (2006) N Engl J Med , vol.354 , pp. 141-150
    • Iacono, A.T.1    Johnson, B.A.2    Grgurich, W.F.3
  • 51
    • 0038690324 scopus 로고    scopus 로고
    • Clinical trials of transplant tolerance: Slow but steady progress
    • Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 2003; 3:794-803.
    • (2003) Am J Transplant , vol.3 , pp. 794-803
    • Matthews, J.B.1    Ramos, E.2    Bluestone, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.